逆流檢測產品市場 - 全球產業規模、佔有率、趨勢、機會、預測：按產品類型、疾病徵兆、最終用戶、地區和競爭格局分類，2021-2031年

全球回流測試產品市場預計將從 2025 年的 37.2 億美元成長到 2031 年的 50.1 億美元，複合年成長率為 5.09%。

此領域涵蓋多種用於測量和識別胃內容物食道逆流的診斷工具，例如食道測壓系統、基於導管的電阻-pH監測儀和無線pH膠囊。推動這一領域發展的主要動力是全球胃食道逆流症（GERD）盛行率的不斷上升。準確客觀的檢驗對於GERD的診斷和有效的手術方案製定至關重要。此外，人口老化和肥胖率的上升也擴大了易患慢性酸性逆流的人群，這需要進行全面的診斷評估，並進一步刺激了市場發展。

然而，傳統導管監測帶來的不適感和病患依從性差是重要的障礙，導致病患猶豫是否接受必要的檢查。這個問題凸顯了診斷需求與患者耐受程度之間的矛盾。根據國際食道疾病學會2025年報告，全球胃食道逆流（GERD）病例預計將增加至約8.26億例，這一數字凸顯了高效反流檢測解決方案的迫切需求。

市場促進因素

巴瑞特氏食道症和食道腺癌發生率的上升凸顯了精準逆流檢測的迫切需求，使其成為一項重要的臨床挑戰。由於慢性胃食道逆流會損傷食道黏膜，因此透過嚴格的電阻和pH監測篩檢癌前細胞變化至關重要。這種迫切性正促使檢測從簡單的症狀管理轉變為預防腫瘤學的關鍵要求。根據美國癌症協會於2024年1月發布的《2024年癌症事實與數據》，預計美國將新增22,370例食道癌病例，這進一步強調了利用先進診斷設備進行早期檢測的必要性。

同時，無線pH監測技術的快速發展正在改變這一領域，解決了導管系統通用的依從性問題。這些先進的膠囊式設備能夠實現長期數據記錄，且不會造成身體不適，使臨床醫生能夠獲得客觀的逆流證據。這項技術進步也體現在主要企業的財務表現中。例如，美敦力公司於2024年5月發布的2024年第四季財報顯示，其醫療外科產品組合的全球銷售額達到22億美元，凸顯了該領域的商業性規模。此外，肥胖率的上升加劇了逆流症狀，也推動了市場的發展。世界衛生組織（WHO）2024年的報告顯示，全球有超過10億人肥胖，這是一個龐大的群體，需要長期的診斷解決方案。

市場挑戰

標準導管監測帶來的不適感和低依從性是阻礙全球逆流檢測產品市場收入成長的主要障礙。電阻-pH監測和食道測壓等檢查通常需要插入鼻胃管，這往往會引起噁心反射、焦慮和明顯的身體不適。這種侵入性操作在治療過程中造成了極大的阻力，導致許多合格的患者拒絕接受確診性檢查或在治療過程中途放棄。因此，醫療服務提供者往往更依賴經驗性治療而非客觀診斷，從而減少了檢測設備的使用，並阻礙了市場滲透。

這種阻力構成了一個特定的瓶頸，阻礙了市場充分利用胃腸道疾病日益普遍的趨勢。根據美國胃腸病學會的報告，到2024年，超過30%的美國成年人每週至少會出現一次胃食道逆流症的症狀。這項統計數據表明，由於傳統導管診斷通訊協定固有的耐受性問題，大量潛在患者群體未能獲得足夠的診斷產品治療。

市場趨勢

將人工智慧 (AI) 整合到反流資料分析中，正在變革診斷軟體，使其從基礎指標發展到自動化模式識別。傳統的追蹤方法會產生大量資料集，這可能導致在人工檢查中遺漏一些細微的變化，例如非酸性逆流發作。如今，人工智慧演算法能夠高精度地識別這些異常情況，從而輔助臨床醫生，降低觀察者間的差異，並提高複雜病例的診斷準確性。這項技術進步得到了強力的臨床證據支持。發表於 2024 年 7 月《JMIR 醫學資訊學》雜誌的一項題為「人工智慧在內視鏡診斷中的準確性：一項綜合綜述」的研究報告稱，人工智慧模型在診斷胃食道逆流疾病方面達到了 97% 的敏感性，顯著優於標準的人工方法。

由於標準的24小時通訊協定常常遺漏常規症狀的波動，臨床上正朝著多日、長期攜帶式監測的方向發展，以應對這項挑戰。醫生越來越依賴長達96小時的無線監測，以便在診斷不明確的病例中可靠地識別病理性酸暴露，而不是依賴短期觀察。這項轉變基於以下證據：更長的監測時間能夠顯著提高對可能被漏診的合格患者的識別率。根據美國胃腸病學會2024年9月發布的題為「長期無線pH監測與24小時電阻電阻監測的診斷率比較」的研究，長期無線監測對胃食道逆流（GERD）的明確診斷率達到50%，而傳統的24小時阻抗監測僅為27%。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球回流檢測產品市場展望

• 市場規模及預測
  • 按金額
• 市佔率及預測
  • 產品類型（導管式診斷產品、膠囊式診斷產品、逆流檢測探針、其他）
  • 按類型分類的疾病徵兆（巴瑞特氏食道症、逆流性食道炎、食道腺癌）
  • 依最終使用者（醫院/診所、門診手術中心、其他）分類
  • 按地區
  • 按公司（2025 年）
• 市場地圖

第6章：北美逆流檢測產品市場展望

• 市場規模及預測
• 市佔率及預測
• 北美洲：國別分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲回流檢測產品市場展望

• 市場規模及預測
• 市佔率及預測
• 歐洲：國別分析
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙

第8章：亞太地區回流檢測產品市場展望

• 市場規模及預測
• 市佔率及預測
• 亞太地區：國別分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：中東和非洲回流檢測產品市場展望

• 市場規模及預測
• 市佔率及預測
• 中東與非洲：國別分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 南非

第10章：南美回流檢測產品市場展望

• 市場規模及預測
• 市佔率及預測
• 南美洲：國別分析
  • 巴西
  • 哥倫比亞
  • 阿根廷

第11章 市場動態

• 促進因素
• 任務

第12章 市場趨勢與發展

• 併購
• 產品發布
• 近期趨勢

第13章：全球回流檢測產品市場：SWOT分析

第14章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的議價能力
• 顧客權力
• 替代品的威脅

第15章 競爭格局

• Medtronic Plc
• Sierra Instruments, Inc.
• Respiratory Technology Corporation
• Ethicon, Inc.
• Medical Measurement Systems BV
• AstraZeneca Plc
• Diversatek, Inc.
• FLSmidth A/S
• Laborie Medical Technologies Corp.
• DRG Instruments GmbH

第16章 策略建議

第17章：關於研究公司及免責聲明

The Global Reflux Testing Products Market is projected to expand from USD 3.72 Billion in 2025 to USD 5.01 Billion by 2031, registering a compound annual growth rate of 5.09%. This sector includes various diagnostic tools such as esophageal manometry systems, catheter-based impedance-pH monitors, and wireless pH capsules, all utilized to measure and identify the regurgitation of stomach contents into the esophagus. A major force driving this expansion is the increasing global prevalence of gastroesophageal reflux disease (GERD), which requires precise objective verification to diagnose conditions and plan surgeries effectively. Additionally, the growing number of aging individuals and rising obesity rates further fuel the market by enlarging the population susceptible to chronic acid reflux, necessitating thorough diagnostic assessments.

However, the industry encounters a notable obstacle due to the discomfort and non-compliance linked to conventional catheter-based monitoring, which discourages patients from proceeding with essential tests. This issue underscores the conflict between the need for diagnosis and what patients are willing to endure. As reported by the International Society for Diseases of the Esophagus in 2025, the global burden of GERD has escalated to roughly 826 million cases, a figure that emphasizes the urgent and expanding need for efficient reflux testing solutions.

Market Driver

The rising incidence of Barrett's esophagus and esophageal adenocarcinoma acts as a vital clinical imperative driving the need for accurate reflux testing. Because chronic gastroesophageal reflux harms the esophageal lining, screening for pre-cancerous cellular changes through rigorous impedance and pH monitoring is essential. This urgency transforms testing from simple symptom management into a critical requirement for preventative oncology. As stated by the American Cancer Society in their January 2024 'Cancer Facts & Figures 2024', an estimated 22,370 new esophageal cancer cases were projected for the United States, reinforcing the necessity for early identification via advanced diagnostic instruments.

Simultaneously, rapid progress in wireless pH monitoring is transforming the sector by addressing the compliance issues common with catheter-based systems. These modern capsule devices enable extended data recording without causing physical distress, thereby encouraging clinicians to rely on objective evidence of reflux. This technological evolution is mirrored in the financial results of leading companies; for instance, Medtronic's 'Fourth Quarter Fiscal 2024 Financial Results' from May 2024 showed their Medical Surgical Portfolio generated $2.2 billion in worldwide revenue, underscoring the segment's commercial magnitude. Furthermore, the market is supported by growing obesity rates that worsen reflux symptoms, with the World Health Organization reporting in 2024 that over 1 billion individuals globally are living with obesity, creating a massive demographic in need of long-term diagnostic solutions.

Market Challenge

The discomfort and lack of compliance associated with standard catheter-based monitoring represent a significant hurdle that directly restricts revenue growth in the Global Reflux Testing Products Market. Procedures like impedance-pH monitoring and esophageal manometry generally involve the transnasal insertion of a catheter, which often triggers gagging, anxiety, and substantial physical irritation. This invasive aspect causes considerable friction during care, leading many eligible patients to decline confirmatory tests or end procedures prematurely. As a result, medical providers frequently resort to empirical medication rather than insisting on objective diagnostics, thereby diminishing the usage of testing devices and curbing market penetration.

This reluctance forms a specific bottleneck that hampers the market's ability to fully benefit from the increasing prevalence of digestive conditions. According to the American Gastroenterological Association, over 30% of adults in the United States reported experiencing symptoms of gastroesophageal reflux disease on at least a weekly basis in 2024. This statistic indicates a vast addressable patient group that remains underserved by diagnostic products largely because of the tolerability challenges embedded in conventional catheter-based protocols.

Market Trends

The integration of Artificial Intelligence into reflux data analysis is transforming diagnostic software by evolving from basic metrics to automated pattern recognition. Traditional tracings produce extensive datasets where minor variations, such as non-acid reflux episodes, might be missed during manual examination. AI algorithms now support clinicians by pinpointing these anomalies with great accuracy, reducing variability between observers and boosting diagnostic certainty in difficult cases. This technological advancement is backed by strong clinical evidence; a study in JMIR Medical Informatics titled 'Diagnostic Accuracy of Artificial Intelligence in Endoscopy: Umbrella Review' from July 2024 noted that AI models achieved a sensitivity of 97% in diagnosing gastroesophageal reflux disease, significantly surpassing standard manual methods.

The shift toward prolonged multi-day ambulatory monitoring marks a clinical progression designed to resolve the shortcomings of standard 24-hour protocols, which frequently miss daily symptom fluctuations. Physicians are increasingly favoring extended wireless monitoring periods lasting up to 96 hours to conclusively identify pathologic acid exposure in unclear cases, rather than depending on shorter observation windows. This change is motivated by evidence showing that longer testing durations considerably improve the identification of eligible patients who might otherwise be overlooked. According to the American College of Gastroenterology's September 2024 study 'Diagnostic Yield of Prolonged Wireless pH vs 24-hour pH-Impedance Monitoring', the diagnostic yield for confirming gastroesophageal reflux disease reached 50% with prolonged wireless monitoring, compared to just 27% using traditional 24-hour impedance monitoring.

Key Market Players

• Medtronic Plc
• Sierra Instruments, Inc.
• Respiratory Technology Corporation
• Ethicon, Inc.
• Medical Measurement Systems BV
• AstraZeneca Plc
• Diversatek, Inc.
• FLSmidth A/S
• Laborie Medical Technologies Corp.
• DRG Instruments GmbH

Report Scope

In this report, the Global Reflux Testing Products Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Reflux Testing Products Market, By Product Type

• Catheter Based Testing Products
• Capsule Based Testing Products
• Reflux Testing Probes
• Others

Reflux Testing Products Market, By Disease Indication

• Barrett's Esophagus
• Reflux Esophagitis
• Esophageal Adenocarcinoma

Reflux Testing Products Market, By End User

• Hospitals &Clinics
• Ambulatory Surgical Centers
• Others

Reflux Testing Products Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Reflux Testing Products Market.

Available Customizations:

Global Reflux Testing Products Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Reflux Testing Products Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product Type (Catheter Based Testing Products, Capsule Based Testing Products, Reflux Testing Probes, Others)
  • 5.2.2. By Disease Indication (Barrett's Esophagus, Reflux Esophagitis, Esophageal Adenocarcinoma)
  • 5.2.3. By End User (Hospitals &Clinics, Ambulatory Surgical Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2025)
• 5.3. Market Map

6. North America Reflux Testing Products Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product Type
  • 6.2.2. By Disease Indication
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Reflux Testing Products Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product Type
      • 6.3.1.2.2. By Disease Indication
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Reflux Testing Products Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product Type
      • 6.3.2.2.2. By Disease Indication
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Reflux Testing Products Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product Type
      • 6.3.3.2.2. By Disease Indication
      • 6.3.3.2.3. By End User

7. Europe Reflux Testing Products Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product Type
  • 7.2.2. By Disease Indication
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Reflux Testing Products Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product Type
      • 7.3.1.2.2. By Disease Indication
      • 7.3.1.2.3. By End User
  • 7.3.2. France Reflux Testing Products Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product Type
      • 7.3.2.2.2. By Disease Indication
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Reflux Testing Products Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product Type
      • 7.3.3.2.2. By Disease Indication
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Reflux Testing Products Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product Type
      • 7.3.4.2.2. By Disease Indication
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Reflux Testing Products Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product Type
      • 7.3.5.2.2. By Disease Indication
      • 7.3.5.2.3. By End User

8. Asia Pacific Reflux Testing Products Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product Type
  • 8.2.2. By Disease Indication
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Reflux Testing Products Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product Type
      • 8.3.1.2.2. By Disease Indication
      • 8.3.1.2.3. By End User
  • 8.3.2. India Reflux Testing Products Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product Type
      • 8.3.2.2.2. By Disease Indication
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Reflux Testing Products Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product Type
      • 8.3.3.2.2. By Disease Indication
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Reflux Testing Products Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product Type
      • 8.3.4.2.2. By Disease Indication
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Reflux Testing Products Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product Type
      • 8.3.5.2.2. By Disease Indication
      • 8.3.5.2.3. By End User

9. Middle East & Africa Reflux Testing Products Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product Type
  • 9.2.2. By Disease Indication
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Reflux Testing Products Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product Type
      • 9.3.1.2.2. By Disease Indication
      • 9.3.1.2.3. By End User
  • 9.3.2. UAE Reflux Testing Products Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product Type
      • 9.3.2.2.2. By Disease Indication
      • 9.3.2.2.3. By End User
  • 9.3.3. South Africa Reflux Testing Products Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product Type
      • 9.3.3.2.2. By Disease Indication
      • 9.3.3.2.3. By End User

10. South America Reflux Testing Products Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product Type
  • 10.2.2. By Disease Indication
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Reflux Testing Products Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product Type
      • 10.3.1.2.2. By Disease Indication
      • 10.3.1.2.3. By End User
  • 10.3.2. Colombia Reflux Testing Products Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product Type
      • 10.3.2.2.2. By Disease Indication
      • 10.3.2.2.3. By End User
  • 10.3.3. Argentina Reflux Testing Products Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product Type
      • 10.3.3.2.2. By Disease Indication
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Reflux Testing Products Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic Plc
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Sierra Instruments, Inc.
• 15.3. Respiratory Technology Corporation
• 15.4. Ethicon, Inc.
• 15.5. Medical Measurement Systems BV
• 15.6. AstraZeneca Plc
• 15.7. Diversatek, Inc.
• 15.8. FLSmidth A/S
• 15.9. Laborie Medical Technologies Corp.
• 15.10. DRG Instruments GmbH

16. Strategic Recommendations

17. About Us & Disclaimer